Human IGG B12 anti- primary HIV-1 isolates (PDB: 1HZH)
Welcome To The Antibody Society Webpage
The Antibody Society was formed in 2007 to further the broad interests of antibody engineering and antibody therapeutics, as well as to safeguard the public interest by increasing discussion and activities to create the safe, thorough testing of antibody therapeutics. The Society encompasses this increasingly diverse field, by supporting the superstructure for the engineering of recombinant antibodies, single scaffold binders, etc. through basic and applied research by those in academics and the private sector. The Society also seeks to provide a forum and voice for the thousands of people now working on all facets of this global field. Read our Mission Statement.
The Antibody Society membership.The Antibody Society website is the vehicle for registration of new members, which is now possible via a secure online server,register here !
News and views
Next Generation Protein Therapeutics Summit !
June 25-27, 2012 - Hyatt at Fisherman's Wharf - San Francisco, CA
Antibody Society members, can save 20% off the standard rates for IBC’s Next Generation Protein Therapeutics Summit.
All you have to do is register with priority code D12198AS. This offer is for new registration only.
Listing of approved monoclonal antibodies ! A list has been composed of all therapeutic monoclonal antibodies approved or in review in the European Union or United States. The information is current as of March 10, 2011. Find the table here !
2010 San Diego - Annual Antibody Engineering and Antibody Therapeutics Meeting Report published !
IBC’s 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of The Antibody Society December 5-9, 2010, San Diego, CA USA
By: Samantha O. Arnett, Jean-Luc Teillaud, Theirry Wurch, Janice M. Reichert, Cameron Dunlop and Michael HuberFind all info here !
Data Standards, an exciting new development! 'The Guidelines for Information About Therapy Experiments (GIATE)' are now available in a Tree format. Find all info here !
Protein Engineering Design & Selection (PEDS) is the Official Journal of The Antibody Society. Each year we devote one issue to our field, which is in September for 2011 (view PEDS online).
The Editorial for this 2011 issue is Open Access, and some articles may be as well.
Otherwise, please use your personal or institutional subscriptions for access. After one
year all papers published in PEDS are Open Access. Thus the previous Antibody
Special Issues may be read in their entirety: April 2010 and March 2009.
Broad coverage of all topics relevant
to antibody research and development
mAbs is the therapeutics journal of The Antibody Society !
